UGER ROBERT (Chief Scientific Officer) sold 3.65K shares of TRILLIUM THERAPEUTICS INC. on the open market
Open‑market sale worth $53.8K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/11/2021ACC: 0001062993-21-000263
Officer· Chief Scientific Officer
Since Jan 2021
-3.65K
Net shares
Net seller
$53.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.65K acquired · 7.29K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+3.65K
Price / share
$0.30
Trade value
$1.09K
% of position
New position
1/7/2021
0.00→3.65K
Common Shares
Direct
Shares
−3.65K
Price / share
$14.75
Trade value
$53.78K
% of position
New position
1/7/2021
3.65K→0.00
Total
Net shares
+0.00
Net value
-$52.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/7/2021 | M · Option Exercise | +3.65K | $0.30 | $1.09K | New position | 0.00 | 3.65K |
| Common Shares Direct | 1/7/2021 | S · Sale | −3.65K | $14.75 | $53.78K | New position | 3.65K | 0.00 |
| Total | +0.00 | -$52.69K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
3.65K shares
Shares
−3.65K
Strike price
0.2987
Held after
123.96K
Exercisable
—
1/7/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares3.65K shares | 1/7/2021 | M · Option Exercise | −3.65K | 0.2987 | — | 123.96K |